Oct 13, 2016 7:05am EDT Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
Oct 11, 2016 7:05am EDT Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe
Sep 23, 2016 7:05am EDT Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences
Sep 20, 2016 7:05am EDT Immunovaccine to Present Pre-Clinical Data at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
Sep 08, 2016 7:05am EDT Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte's IDO1 Enzyme Inhibitor Epacadostat
Sep 01, 2016 7:05am EDT Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference
Aug 25, 2016 7:05am EDT Immunovaccine Announces Additional Positive Topline Results from Phase 1/1b Clinical Trial Program With DPX-Survivac in Ovarian Cancer
Aug 09, 2016 5:05pm EDT Immunovaccine Provides Corporate Update and Announces Second Quarter 2016 Financial Results